Sohini Das, Sundar Sethuraman

Stories by Sohini Das, Sundar Sethuraman

FPI buying lifts Sensex 14% since Oct 2018

FPI buying lifts Sensex 14% since Oct 2018

Rediff.com   17 Mar 2019

Global funds have pumped in over Rs 38,000 crore (about $5.5 billion) into domestic equities since February 20, helping the Sensex rebound 2,671 points, or 7.6 per cent, from its 2019 low.

Why cold wave across US is good news for Indian drug cos

Why cold wave across US is good news for Indian drug cos

Rediff.com   12 Mar 2019

Companies such as Cadila Healthcare, Lupin, and Natco, which sell generic versions of flu medication in the US market, are likely to benefit.

Investors see opportunity in mid, small caps

Investors see opportunity in mid, small caps

Rediff.com   6 Mar 2019

The mid- and small-cap indices had a dream run between January 2017 and January 2018 - zooming 48 per cent and 56 per cent, respectively.

Markets are still not ready to raise fund for capex purpose

Markets are still not ready to raise fund for capex purpose

Rediff.com   21 Feb 2019

While the fresh issue portion of IPOs has been going down over the years, this financial year has been abysmally low at only Rs 2,663 crore, 82 per cent lower compared to the last financial year.

2 reasons why India's market capitalisation is down $274 billion

2 reasons why India's market capitalisation is down $274 billion

Rediff.com   18 Feb 2019

The weakness in the rupee and broader markets has led to evaporation in the market cap.

Will Chalet Hotels IPO revive the market?

Will Chalet Hotels IPO revive the market?

Rediff.com   28 Jan 2019

Five to six issues may hit the market if Chalet Hotels's IPO is successful and if there are no negative surprises in the Union Budget on February 1.

'Rs 600 bn worth of IPOs yet to hit markets'

'Rs 600 bn worth of IPOs yet to hit markets'

Rediff.com   14 Jan 2019

'IPOs not clicking is cause for worry,' says Sebi chairman.

Jio likely to grab 51% revenue market share in 3 years

Jio likely to grab 51% revenue market share in 3 years

Rediff.com   7 Jan 2019

Airtel and Vodafone Idea are also trying to expand the penetration of 4G users in their subscriber base as they take this network to the hinterland

India Inc's Rs 1-trillion club shrinks in 2018

India Inc's Rs 1-trillion club shrinks in 2018

Rediff.com   17 Dec 2018

Automobile company Tata Motors, metals and mining major Vedanta, oil marketing firm Bharat Petroleum Corporation (BPCL), private sector IndusInd Bank, and two-wheeler major Bajaj Auto have witnessed their market cap slip below the Rs 1-trillion mark this year.

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Rediff.com   6 Dec 2018

Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.

Fundraising through rights issue hits 10-year high

Fundraising through rights issue hits 10-year high

Rediff.com   21 Nov 2018

So far, nine companies have raised Rs 17,860 crore - nearly three times of last year's tally - by way of rights issues.

Markets post third straight weekly gain

Markets post third straight weekly gain

Rediff.com   17 Nov 2018

After a sharp sell-off in the past two months, overseas investors were once again seen turning bullish on Indian equities. FIIs bought shares worth Rs 63.5 billion in the past five sessions, their highest weekly investment tally in many months.

Bhavdeep Singh, the CEO who championed organ donation quits Fortis

Bhavdeep Singh, the CEO who championed organ donation quits Fortis

Rediff.com   9 Nov 2018

Singh, who was instrumental in building required capabilities in the organisation said his role at Fortis did not allow him to spend time with his family, as the reason behind his resignation.

J&J's loss may be good news for Indian pharmas

J&J's loss may be good news for Indian pharmas

Rediff.com   1 Nov 2018

Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga

Why drug firms' Q2 revenue growth is likely to dip

Why drug firms' Q2 revenue growth is likely to dip

Rediff.com   12 Oct 2018

Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating against rupee.

Quality perceptions hobble Jan Aushadi drugs

Quality perceptions hobble Jan Aushadi drugs

Rediff.com   10 Oct 2018

Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain their affordability.

Why draft pharma policy may take time to see light of day

Why draft pharma policy may take time to see light of day

Rediff.com   25 Sep 2018

Some of the proposals (for example trade margin calculation for imported medical devices) were not approved by the PMO and were sent back for revisions.

How Amul is quelling the 'non-veg' rumours

How Amul is quelling the 'non-veg' rumours

Rediff.com   21 Sep 2018

This is not the first time Gujarat Cooperative Milk Marketing Federation that owns brand Amul has chosen an unconventional method to protect its brand.

For Singh brothers, truce is temporary, split only way out

For Singh brothers, truce is temporary, split only way out

Rediff.com   15 Sep 2018

NCLT allows Shivinder to withdraw petition against his brother Malvinder. Final decision to be taken by family members in their presence.

Shivinder vs Malvinder: Mother helps avoid legal battle for now

Shivinder vs Malvinder: Mother helps avoid legal battle for now

Rediff.com   14 Sep 2018

Sources said she had stopped eating for the past few days and had constantly been making calls and sending emails to the two brothers.